Actin-independent exclusion of CD95 by PI3K/AKT signalling: Implications for apoptosis

European Journal of Immunology

Volumn 41, Issue 8, 2011, Pages 2368-2378

  Pizon, Mathieu ^a,b   Rampanarivo, Hariniaina ^c   Tauzin, Sébastien ^c   Chaigne Delalande, Benjamin ^a,b   Daburon, Sophie ^a,b   Castroviejo, Michel ^b,d   Moreau, Patrick ^b,e   Moreau, Jean François ^a,b,f   Legembre, Patrick ^c  

^a CNRS Bordeaux Segalen University   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

^d University Victor Segalen   (France)

^e University Victor Segalen   (France)

^f BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

Akt; Apoptosis; CD95; Lipid rafts; PI3K

Indexed keywords

ACTIN; FAS ANTIGEN; FAS LIGAND; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE IA; PROTEIN KINASE B; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL MEMBRANE; CELL TYPE; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVITY; ENZYME INHIBITION; GENE DISRUPTION; HUMAN; HUMAN CELL; LIPID RAFT; MOLECULAR MECHANICS; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 79960709813     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201041078     Document Type: Article

References (38)

1. Berke, G., The CTL's kiss of death. Cell 1995. 81: 9-12.
2. Kischkel, F. C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer, P. H. and Peter, M. E., Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 1995. 14: 5579-5588.
3. Beneteau, M., Pizon, M., Chaigne-Delalande, B., Daburon, S., Moreau, P., De Giorgi, F., Ichas, F. et al., Localization of Fas/CD95 into the lipid rafts on down-modulation of the phosphatidylinositol 3-kinase signaling pathway. Mol. Cancer Res. 2008. 6: 604-613.
4. Hueber, A. O., Bernard, A. M., Herincs, Z., Couzinet, A. and He, H. T., An essential role for membrane rafts in the initiation of Fas/CD95-triggered cell death in mouse thymocytes. EMBO Rep. 2002. 3: 190-196.
5. Legembre, P., Daburon, S., Moreau, P., Ichas, F., de Giorgi, F., Moreau, J. F. and Taupin, J. L., Amplification of Fas-mediated apoptosis in type II cells via microdomain recruitment. Mol. Cell. Biol. 2005. 25: 6811-6820.
6. Legembre, P., Daburon, S., Moreau, P., Moreau, J. F. and Taupin, J. L., Cutting edge: modulation of fas-mediated apoptosis by lipid rafts in T lymphocytes. J. Immunol. 2006. 176: 716-720.
7. Stel, A. J., Ten Cate, B., Jacobs, S., Kok, J. W., Spierings, D. C., Dondorff, M., Helfrich, W. et al., Fas receptor clustering and involvement of the death receptor pathway in rituximab-mediated apoptosis with concomitant sensitization of lymphoma B cells to fas-induced apoptosis. J. Immunol. 2007. 178: 2287-2295.
8. Delmas, D., Rebe, C., Lacour, S., Filomenko, R., Athias, A., Gambert, P., Cherkaoui-Malki, M. et al., Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells. J. Biol. Chem. 2003. 278: 41482-41490.
9. Delmas, D., Rebe, C., Micheau, O., Athias, A., Gambert, P., Grazide, S., Laurent, G. et al., Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells. Oncogene 2004. 23: 8979-8986.
10. Gajate, C. and Mollinedo, F., The antitumor ether lipid ET-18-OCH(3) induces apoptosis through translocation and capping of Fas/CD95 into membrane rafts in human leukemic cells. Blood 2001. 98: 3860-3863.
11. Lacour, S., Hammann, A., Grazide, S., Lagadic-Gossmann, D., Athias, A., Sergent, O., Laurent, G. et al., Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells. Cancer Res. 2004. 64: 3593-3598.
12. Barnhart, B. C., Alappat, E. C. and Peter, M. E., The CD95 type I/type II model. Semin. Immunol. 2003. 15: 185-193.
13. Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K. J., Debatin, K. M. et al., Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 1998. 17: 1675-1687.
14. Xavier, R., Brennan, T., Li, Q., McCormack, C. and Seed, B., Membrane compartmentation is required for efficient T cell activation. Immunity 1998. 8: 723-732.
15. Calleja, V., Laguerre, M., Parker, P. J. and Larijani, B., Role of a novel PH-kinase domain interface in PKB/Akt regulation: structural mechanism for allosteric inhibition. PLoS Biol. 2009. 7: e17.
16. Thimmaiah, K. N., Easton, J. B., Germain, G. S., Morton, C. L., Kamath, S., Buolamwini, J. K. and Houghton, P. J., Identification of N10-substituted phenoxazines as potent and specific inhibitors of Akt signaling. J. Biol. Chem. 2005. 280: 31924-31935.
17. Siegel, R. M., Frederiksen, J. K., Zacharias, D. A., Chan, F. K., Johnson, M., Lynch, D., Tsien, R. Y. et al., Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science 2000. 288: 2354-2357.
18. Weinstein, I. B., Cancer. Additiona to oncogenes - the Achilles heal of cancer. Science 2002. 297: 63-64.
19. Gajate, C., Del Canto-Janez, E., Acuna, A. U., Amat-Guerri, F., Geijo, E., Santos-Beneit, A. M., Veldman, R. J. et al., Intracellular triggering of Fas aggregation and recruitment of apoptotic molecules into Fas-enriched rafts in selective tumor cell apoptosis. J. Exp. Med. 2004. 200: 353-365.
20. Muppidi, J. R. and Siegel, R. M., Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death. Nat. Immunol. 2004. 5: 182-189.
21. Chaigne-Delalande, B., Moreau, J. F. and Legembre, P., Rewinding the DISC. Arch. Immunol. Ther. Exp. (Warsz). 2008. 56: 9-14.
22. Parlato, S., Giammarioli, A. M., Logozzi, M., Lozupone, F., Matarrese, P., Luciani, F., Falchi, M. et al., CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway. EMBO J. 2000. 19: 5123-5134.
23. Zhu, L., Zhou, R., Mettler, S., Wu, T., Abbas, A., Delaney, J. and Forte, J. G., High turnover of ezrin T567 phosphorylation: conformation, activity, and cellular function. Am. J. Physiol. Cell. Physiol. 2007. 293: C874-C884.
24. Lozupone, F., Lugini, L., Matarrese, P., Luciani, F., Federici, C., Iessi, E., Margutti, P. et al., Identification and relevance of the CD95-binding domain in the N-terminal region of ezrin. J. Biol. Chem. 2004. 279: 9199-9207.
25. Turunen, O., Wahlstrom, T. and Vaheri, A., Ezrin has a COOH-terminal actin-binding site that is conserved in the ezrin protein family. J. Cell. Biol. 1994. 126: 1445-1453.
26. Chaigne-Delalande, B., Mahfouf, W., Daburon, S., Moreau, J. F. and Legembre, P., CD95 engagement mediates actin-independent and -dependent apoptotic signals. Cell Death Differ. 2009. 16: 1654-1664.
27. Stancevic, B. and Kolesnick, R., Ceramide-rich platforms in transmembrane signaling. FEBS Lett. 2010. 584: 1728-1740.
28. Rebillard, A., Tekpli, X., Meurette, O., Sergent, O., LeMoigne-Muller, G., Vernhet, L., Gorria, M. et al., Cisplatin-induced apoptosis involves membrane fluidification via inhibition of NHE1 in human colon cancer cells. Cancer Res. 2007. 67: 7865-7874.
29. Cremesti, A., Paris, F., Grassme, H., Holler, N., Tschopp, J., Fuks, Z., Gulbins, E. et al., Ceramide enables fas to cap and kill. J. Biol. Chem. 2001. 276: 23954-23961.
30. Burow, M. E., Weldon, C. B., Collins-Burow, B. M., Ramsey, N., McKee, A., Klippel, A., McLachlan, J. A. et al., Cross-talk between phosphatidylinositol 3-kinase and sphingomyelinase pathways as a mechanism for cell survival/death decisions. J. Biol. Chem. 2000. 275: 9628-9635.
31. Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J. et al., Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999. 96: 857-868.
32. Cardone, M. H., Roy, N., Stennicke, H. R., Salvesen, G. S., Franke, T. F., Stanbridge, E., Frisch, S. et al., Regulation of cell death protease caspase-9 by phosphorylation. Science 1998. 282: 1318-1321.
33. Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y. and Greenberg, M. E., Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997. 91: 231-241.
34. Peacock, J. W., Palmer, J., Fink, D., Ip, S., Pietras, E. M., Mui, A. L., Chung, S. W. et al., PTEN loss promotes mitochondrially dependent type II Fas-induced apoptosis via PEA-15. Mol. Cell. Biol. 2009. 29: 1222-1234.
35. Trencia, A., Perfetti, A., Cassese, A., Vigliotta, G., Miele, C., Oriente, F., Santopietro, S. et al., Protein kinase B/Akt binds and phosphorylates PED/PEA-15, stabilizing its antiapoptotic action. Mol. Cell. Biol. 2003. 23: 4511-4521.
36. Panka, D. J., Mano, T., Suhara, T., Walsh, K. and Mier, J. W., Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells. J. Biol. Chem. 2001. 276: 6893-6896.
37. Guidicelli, G., Chaigne-Delalande, B., Dilhuydy, M. S., Pinson, B., Mahfouf, W., Pasquet, J. M., Mahon, F. X. et al., The necrotic signal induced by mycophenolic acid overcomes apoptosis-resistance in tumor cells. PLoS One 2009. 4: e5493.
38. Legembre, P., Moreau, P., Daburon, S., Moreau, J. F. and Taupin, J. L., Potentiation of Fas-mediated apoptosis by an engineered glycosylphosphatidylinositol-linked Fas. Cell. Death Differ. 2002. 9: 329-339.